Healthy Skepticism Library item: 3400

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MLAM letter follow up—Pfizer
MLAM Newsletter 1986 Nov;

Abstract:

Pfizer responded to the MLAM letter about tetracycline syrup for children after a complaint was made to the International Federation of Pharmaceutical Manufacturers Associations.

Keywords:
*analysis/developing countries/tetracycline/children/Pfizer/ company responses/ International Federation of Pharmaceutical Manufacturers Associations/ IFPMA/ Code of Pharmaceutical Marketing Practices (IFPMA)/MaLAM/Medical Lobby for Appropriate Marketing/antibiotics/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION